Company BioGend Therapeutics Co., Ltd.

Equities

6733

TW0006733009

Biotechnology & Medical Research

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Company contact information

Sector

Sales per region

Annual profits - Rate of surprise

Sector Other Biotechnology & Medical Research

End-of-day quote Taipei Exchange Other stock markets 06:00:00 2024-07-16 pm EDT			5-day change	1st Jan Change
37.7 ^TWD	+0.80%		-0.40%	-1.44%

May. 28	BioGend Therapeutics Co., Ltd. Announces Hsinchu Factory Pass the Domestic Medical Device Quality Management System Manufacturing License	CI
May. 10	BioGend Therapeutics Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

BIOGEND THERAPEUTICS CO., LTD. is a medical equipment company mainly engaged in the development of biological aggregate. The Company is mainly engaged in the development and research of high-grade bone filling materials and knee cartilage repair related medical equipment. The Company's main products are BiG-001 which used for long bone biological aggregate, BiG-006 that used for lumbar interbody fusion biological bone, as well as BiG-009.

TWD in Million	2022	Weight	2023	Weight	Delta
Orthopedic Medical Devices 100.0 %	31	100.0 %	110	100.0 %	+249.51%

TWD in Million	2022	Weight	2023	Weight	Delta
Taiwan 66.9 %	31	99.0 %	74	66.9 %	+136.18%
Japan 22.6 %	0	0.0 %	25	22.6 %	+248,700.00%
Others 10.5 %	0	1.0 %	11	10.5 %	+3,730.67%

Managers	Title	Age	Since
Te Li Chen CEO	Chief Executive Officer	55	16-07-06
Tsang Cheng Lin CEO	Chief Executive Officer	-	18-04-29
Shu Wei Chao DFI	Director of Finance/CFO	-	-
Liang Yan Wang IRC	Investor Relations Contact	-	17-08-31
Po Chih Chang PRN	Corporate Officer/Principal	-	17-07-31

Members of the board	Title	Age	Since
Jung Chin Lin BRD	Director/Board Member	70	19-05-19
Hai Yi Ma BRD	Director/Board Member	-	18-05-19
Te Li Chen CEO	Chief Executive Officer	55	16-07-06
Shao Feng Chien BRD	Director/Board Member	-	18-05-19
Tsang Cheng Lin CEO	Chief Executive Officer	-	18-04-29
Hsuan hao Chang BRD	Director/Board Member	-	18-05-19
En Tzu Liu BRD	Director/Board Member	-	19-05-19

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	124,256,026	74,573,026 ( 60.02 %)	0	60.02 %

BioGend Therapeutics Co., Ltd.

4th Floor No.3 Park Street

115 03, Taipei

http://www.biogend.com.tw

address BioGend Therapeutics Co., Ltd.(6733)

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

37.7 TWD

Average target price

48 TWD

Spread / Average Target

+27.32%

Consensus

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research

	1st Jan change	Capi.
BIOGEND THERAPEUTICS CO., LTD.	-1.44%	144M
MODERNA, INC.	+24.74%	47.54B
IQVIA HOLDINGS INC.	-0.47%	41.96B
LONZA GROUP AG	+45.89%	41.55B
ALNYLAM PHARMACEUTICALS, INC.	+25.40%	30.36B
ICON PUBLIC LIMITED COMPANY	+17.96%	27.61B
CELLTRION, INC.	-4.47%	28.7B
UNITED THERAPEUTICS CORPORATION	+50.73%	14.7B
MEDPACE HOLDINGS, INC.	+42.56%	13.51B
BIO-TECHNE CORPORATION	+1.46%	12.34B

Other Biotechnology & Medical Research